Which medications in the drug class Tumor Necrosis Factor Blockers are used in the treatment of Reactive Arthritis?

Updated: Dec 24, 2020
  • Author: Carlos J Lozada, MD; Chief Editor: Herbert S Diamond, MD  more...
  • Print

Tumor Necrosis Factor Blockers

Anti–tumor necrosis factor (TNF)–α therapy may be considered in refractory cases of ReA.

Infliximab (Remicade)

Infliximab is a chimeric IgG1κ monoclonal antibody that binds specifically to the soluble and transmembrane forms of TNF-α and inhibits the binding of TNF-α to its receptors.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!